✦ LIBER ✦

Report of successful use of ustekinumab in Crohn’s disease refractory to three anti-TNF therapies

✍ Scribed by Heetun, Z. S.; Keegan, D.; O’Donoghue, D.; Doherty, G. A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Untoward effect of anti-TNF therapy in C

✍ Annese, V.; Lombardi, G.; Napolitano, G.; Caruso, N.; Conoscitore, P.; Andriulli 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Effect of anti-TNF therapy on lymphocyte

✍ A.G. Bonanomi; S. Bagnoli; G. d'Albasio; M. Milla; M. Stio; M. Martinesi; C. Tre 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 161 KB

P425 One-year outcomes of ustekinumab th

✍ Ginard, D.; Khorrami, S.; Marín, I.; Chaparro, M.; Aguas, M.; Martínez-González, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 53 KB

Mo1197 Dermatological Complications of A

✍ Nardelli, Andrea; Chauhan, Usha K.; Marshall, John K.; Halder, Smita L.; Tse, Fr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Anti-TNF antibody therapy in Crohn's dis

✍ Ricart, E.; Ordas, I.; Panes, J. 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 62 KB

Long-term efficacy of adalimumab in Paed

✍ J. Martín-de-Carpi; N. Pociello; V. Varea 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 177 KB